Commerzbank Aktiengesellschaft FI Has $1.66 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Commerzbank Aktiengesellschaft FI lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 3.4% in the first quarter, HoldingsChannel.com reports. The fund owned 6,282 shares of the insurance provider’s stock after acquiring an additional 208 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Humana were worth $1,663,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of the company. Achmea Investment Management B.V. raised its holdings in shares of Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock worth $2,746,000 after purchasing an additional 49 shares during the period. Beech Hill Advisors Inc. boosted its position in shares of Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after purchasing an additional 50 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its position in shares of Humana by 15.8% during the 1st quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider’s stock valued at $122,000 after purchasing an additional 63 shares in the last quarter. Vise Technologies Inc. boosted its holdings in shares of Humana by 8.0% in the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider’s stock worth $221,000 after buying an additional 65 shares during the period. Finally, Versant Capital Management Inc boosted its holdings in shares of Humana by 17.1% during the first quarter. Versant Capital Management Inc now owns 453 shares of the insurance provider’s stock worth $120,000 after purchasing an additional 66 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on HUM shares. Truist Financial dropped their price target on shares of Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a research report on Wednesday. Barclays set a $268.00 price target on shares of Humana and gave the stock an “equal weight” rating in a research report on Thursday, June 12th. Guggenheim started coverage on Humana in a research note on Wednesday, April 9th. They issued a “buy” rating and a $326.00 price target for the company. Wall Street Zen lowered Humana from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Finally, Bank of America reduced their price target on Humana from $320.00 to $260.00 and set a “neutral” rating for the company in a research report on Tuesday, June 17th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $279.81.

Humana Stock Down 1.3%

Shares of NYSE HUM opened at $223.68 on Friday. Humana Inc. has a 12-month low of $212.45 and a 12-month high of $406.46. The stock’s fifty day simple moving average is $235.46 and its two-hundred day simple moving average is $257.46. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $27.00 billion, a PE ratio of 15.82, a price-to-earnings-growth ratio of 1.55 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. Humana’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the business earned $7.23 EPS. As a group, analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.